The alkylating agent cyclophosphamide (Cy) alters (suppresses or enhances) immune responses in vivo (1-5) but does not act on lymphocyte functions in vitro. The lack of in vitro effects of Ely is a result of the fact that Ely has to be metabolized into the active compounds which are formed by a sequence of reactions catalyzed by microsomal enzymes in the liver (6). It has been shown that Ely activated by liver microsomes in vitro acts as an immunosuppressive in vitro (7). 4-hydroperoxycyclophosphamide (4HP-Ely) is a relatively stable derivative of Cy which is spontaneously converted in aqueous solution into 4-hydroxycyclophosphamide, the naturally occurring, but very unstable, metabolite of Ely. Recently, it has been reported (6) that 4HP-Ely acts like activated Ely immunosuppressive in vitro. In this report, we present results which show that (a) lymphocyte functions, as analyzed by their capacity to respond to mitogens in vitro can be influenced (enhanced or suppressed) by pretreatment of the cell donors in vivo by Cy or by treatment of the ceils in vitro with 4HP-Ely, and that (b) the enhancement of the mitogenic response of dextran sulfate-reactive B lymphocytes by Cy or 4HP-Ely is a result of functional inactiyation of T-suppressor cells by these drugs, and that (c) B lymphocytes are less sensitive to Ely or 4HP-Cy action than this type of T-suppressor cell.
(C) from Behring-Werke AG, Marburg/Lahn, Federal Republic of Germany; fetal calf serum (FCS), batch No. 104 from Seromed, Munich, Federal Republic of Germany; and RPMI-1640 medium from Microbiological Associates, Walkersville, Md. were used.
Cell Suspensions. Spleen cell and thymocyte suspensions were prepared in serum-free culture medium, as described earlier (8) .
Anti-Theta Serum and Complement Treatment. 1 × 10 v spleen cells were incubated at room temperature for 30 min with anti-Thy-l.2 antiserum (final dilution 1:3,000). The cells were washed, resuspended at a concentration of 107" m1-1 in agarose-adsorbed C (final dilution 1:6) and kept for 60 min at 37°C. The cells were washed and resuspended at a concentration of 2 × 106 viable cells (as determined by the trypan blue dye exclusion test) per ml in serumsupplemented culture medium. were incubated with various doses of 4HP-Cy )0.1-10/~g. m1-1) for 1 h at 37°C in an atmosphere of 5% CO2 in air. As determined by trypan blue dye exclusion test, 4HP-Cy treatment did not change viability of the cells.
Cell Cultures and Determination of [SH]Thymidine ([3H]TdR) Uptake by the Cells. Conditions for
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cell cultures and for determination of [ H]TdR uptake by the cells has been described in detail earlier (9) . Briefly, cells were cultured in triplicates in a total vol of 0.2 ml (2 × 106 cells. m1-1) in microtiter plates (M24AR, Greiner, Niirtingen, Federal Republic of Germany) in an atmosphere of 5% CO2 in air at 37°C for 2 or 4 d in RPMI-1640 medium supplemented with 5% FCS, 5 X 10 -5 M 2-mercaptoethanol, 2 mM L-glutamine.ml-1; 100 U penicillin.ml -I, and 100/~g.m1-1 streptomycin. 0.1 /~Ci of [3H]TdR (sp act: 2 Ci.mM -1, Radioehemical Centre, Amersham, England) was added to the cultures for the last 4 h of the incubation period. Cells were collected on glass-fiber filters using a Skatron multiple cell culture collector (Flow Laboratories, Roekville, Md.). Incorporation of [3H]TdR into the nuclear DNA was then determined as described previously (9) .
The results are expressed as A counts/minute per culture (counts per minute in mitogentreated culture -counts per minute in control cultures) or as stimulation indices (counts per minute in mitogen-treated cultures per counts per minute in control culture). Each value represents the arithmetic mean of A counts per minute detected in triplicate cultures, SE was <10%.
Results and Discussion
Administraaion of Cy, as a rule, results in either immunosuppression, or immune tolerance (1). However, Cy injected several days before antigen administration paradoxically enhances T-cell-mediated, e.g., delayed type of hypersensitivity (DTH) (2), as well as humoral, e.g., to a synthetic antigen (3), immune responses. Suppression of antibody formation, as well as enhancement of DTH induction by the drug has been originally attributed to preferential elimination of short-lived B lymphocytes in the lymphoid organs (2, 10) . Recently, the enhancing effect of Cy on DTH (4), as well as on humoral immune responses (3), has been attributed to elimination of Tsuppressor cells. Along these lines, we presented results indicating that Cy-sensitive Tsuppressor cells control the generation, as well as the expression of activity of autoreactive T cells in vivo (5) . The results suggested that T-suppressor cells (or their precursors) should be more sensitive to Cy treatment in vivo than B lymphocytes or other T-cell subsets mediating various immunological activities.
A direct proof for these suggestions was lacking until now, because Cy does not act in vitro on lymphocytes. Recently, Shand and Howard (6) showed that Cy activated with microsomal enzymes in vitro, as well as derivatives of Cy, e.g., 4HP-Cy, can be used for in vitro studies. They reported that B, as well as T lymphocytes treated in vitro with either activated Cy or with 4HP-Cy transiently lost their capacity to give immune responses (6, 7) . changes in their capacity to respond to two different B-cell mitogens (Fig. 1) . As compared to controls, the response was enhanced to DS (up to eightfold) and diminished to LPS (up to 50%). The response of the cells to Con A was unchanged. Five individual experiments gave essentially identical results.
If one accepts the concept that DS and LPS act on different subsets of B lymphocytes (11), one of the possible explanations of this phenomenon could be that after damage of the spleen by Cy, less-mature DS-reactive B cells may repopulate the spleen earlier than more-mature LPS-reactive B ceils. Alternatively, both types of B lymphocytes should be sensitive to Cy, but in contrast to the LPS-reactive cells, the DS-reactive cells should be under the negative control of Cy-sensitive suppressor cells. These suppressor cells (T-suppressor ceils?) should be more sensitive to Cy action than B lymphocytes and may repopulate the spleen later than the DS-reactive and the LPSreactive cells. If so, the net effect of Cy treatment would be an enhanced response to DS and a diminished response to LPS.
The addition of graded number of thymocytes decreases the enhanced response of the cells to DS, but even slightly enhanced the response of the cells to LPS (Fig. 1) . Pretreatment of the thymocytes with presumably nontoxic doses of 4HP-Cy (1 ~tg per 107 cells) abrogated the capacity of thymocytes to suppress the enhanced DS response but did not significantly change the effect of thymocytes on the LPS response.
TABLE I
Diminished Mitogenic Response to DS and to LPS by 4HP-Cy Using T-Cell-depleted Spleen Cells
Source These results indicated, but did not directly prove the negative control by Cysensitive T lymphocytes on the proliferation of the DS-reactive B-lymphocyte subset. Experiments performed in vitro using 4HP-Cy--an in vitro active derivative of Cy--clearly demonstrate the validity of this suggestion.
Spleen cells of normal mice pretreated with small doses of 4HP-Cy showed an enhanced response to DS, whereas pretreatment of tl~ cells with high doses of this drug diminished the response of the cells to DS. In contrast, the LPS-reactivity of the cells was either unchanged or diminished by small and drastically diminished by high doses of 4HP-Cy (Fig. 2) .
If one assumes the inactivation by 4HP-Cy of T-suppressor cells is responsible for the enhanced DS response, no such effects should be detectable using spleen cells depleted ofT cells or lacking functionally active T cells. As shown previously (8) , and as seen in Table I , anti-theta serum-and-C-treated spleen cells or spleen ceils of nude mice give a higher response to DS than normal spleen cells. The LPS reactivity was unchanged. As expected, the response to DS and to LPS was diminished by treatment of T-cell-depleted spleen cells with 4HP-Cy. The same dose of 4HP-Cy enhanced the response of normal spleen cells to DS. In addition, these results ruled out the possibility of a selective and direct potentionating effect of Cy, or of its active metabolites on DS-reactive B ceils.
In conclusion, our results demonstrate directly (a) that lymphocytes can generally be functionally inactivated by Cy or by its active metabolites, (b) that, as expected from indirect in vivo experiments, T-suppressor cells (or their precursors) are more sensitive to Cy than B lymphocytes, and (c) suggest that the DS-reactive, but not the LPS-reactive, B-lymphocyte subset is under the negative control of T lymphocytes. The results show (a) that in contrast to the LPS-reactive B-lymphocyte subset, the proliferative capacity of DS-reactive subset is negatively controlled by a Cy-and 4HP-Cy-sensitive T-cell subset and (b) that these T-suppressor cells are more sensitive to Cy and 4HP-Cy (to their respective active alkylating metabolites) than B lymphocytes and T cells carrying other immunological functions.
